Union MidCap Fund
The Scheme seeks to achieve long term capital appreciation and generate income by investing predominantly in equity and equity related securities of mid cap companies.
Growthvine rating: 2/5 — ranked #20 of 34 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹47.30 (as of 2026-10-23) |
|---|
| AUM | ₹1,906 Cr |
|---|
| Expense ratio | 1.77% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Gaurav Chopra |
|---|
| Exit load | 1% for redemption within 15 days |
|---|
Performance & risk
| 5-year annualised return | 12.67% |
|---|
| Sharpe ratio | 0.52 |
|---|
| Standard deviation | 17.74% |
|---|
| Max drawdown | −21.72% |
|---|
| Alpha | 0.68 |
|---|
| Beta | 0.93 |
|---|
Over 5 years, captured 91.1% of NIFTY Midcap 150's upside and 93.6% of its downside.
Market cap allocation
| Large cap | 15.8% |
|---|
| Mid cap | 67.8% |
|---|
| Small cap | 16.3% |
|---|
Concentration
| Top 5 holdings | 14.1% |
|---|
| Top 10 holdings | 25.1% |
|---|
| Total holdings | 75 |
|---|
| Index overlap | 36.1% |
|---|
| Active share | 63.9% |
|---|
Top holdings
- One 97 Communications Limited — 3.1%
- Federal Bank Ltd. — 3.0%
- Multi Commodity Exchange of India Ltd — 2.9%
- Max Financial Services Limited — 2.6%
- Ipca Laboratories Ltd. — 2.5%
- GE Vernova T&D India Limited — 2.4%
- NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED — 2.2%
- Fortis Healthcare Ltd — 2.2%
- Bharat Heavy Electricals Ltd. — 2.1%
- Ajanta Pharma Ltd. — 2.1%
Top sectors
- Banking & Financial — 16.4%
- Automobile — 9.8%
- Energy — 9.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −2.7% | Q2 | #9 of 31 |
| 2025 | 2.3% | Q2 | #14 of 29 |
| 2024 | 28.6% | Q3 | #16 of 29 |
| 2023 | 32.2% | Q4 (Bottom) | #23 of 28 |
| 2022 | −2.3% | Q4 (Bottom) | #19 of 22 |